Resveratrol inhibits nonalcoholic fatty liver disease in rats-Reference-Cited by-同舟云学术

Resveratrol inhibits nonalcoholic fatty liver disease in rats

Published:2008-09-09 Issue:1 Volume:8 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Bujanda Luis,Hijona Elizabeth,Larzabal Mikel,Beraza Marta,Aldazabal Pablo,García-Urkia Nerea,Sarasqueta Cristina,Cosme Angel,Irastorza Belen,González Alberto,Arenas Juan I

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-8-40/fulltext.html

Reference37 articles.

1. Sheth SG, Gordon FD, Chopra S: Nonalcoholic steatohepatitis. Ann Intern Med. 1997, 126 (2): 137-45.

2. Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotle DP: Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol. 2007, 102 (2): 399-408. 10.1111/j.1572-0241.2006.01041.x.

3. Arun J, Clements RH, Lazenby AJ, Leeth RR, Abrams GA: The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg. 2006, 16 (10): 1351-1358. 10.1381/096089206778663715.

4. Shapiro H, Halpern Z, Bruck R: Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut. 2007, 56 (3): 426-435. 10.1136/gut.2006.094599.

5. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kingonorn AD, Metha RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997, 275 (5297): 218-220. 10.1126/science.275.5297.218.

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment;Medicinal Chemistry Research;2024-06-26

3. Protective Effects of Resveratrol on Cytotoxicity of Mouse Hepatic Stellate Cells Induced by PM2.5;Atmosphere;2024-05-12

4. Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?;International Journal of Molecular Sciences;2024-03-27

5. Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade;Biomedicine & Pharmacotherapy;2023-09